IL313526A - Nitric oxide-releasing nasal preparations and methods of using them - Google Patents

Nitric oxide-releasing nasal preparations and methods of using them

Info

Publication number
IL313526A
IL313526A IL313526A IL31352624A IL313526A IL 313526 A IL313526 A IL 313526A IL 313526 A IL313526 A IL 313526A IL 31352624 A IL31352624 A IL 31352624A IL 313526 A IL313526 A IL 313526A
Authority
IL
Israel
Prior art keywords
composition
buffer
sodium
nitric oxide
optionally
Prior art date
Application number
IL313526A
Other languages
English (en)
Hebrew (he)
Inventor
Carri Brodnax Geer
Benjamin Joseph Monroe Privett
Daniel Albert Riccio
Shaylyn Elizabeth Walter
Original Assignee
Lnhc Inc
Carri Brodnax Geer
Benjamin Joseph Monroe Privett
Daniel Albert Riccio
Shaylyn Elizabeth Walter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lnhc Inc, Carri Brodnax Geer, Benjamin Joseph Monroe Privett, Daniel Albert Riccio, Shaylyn Elizabeth Walter filed Critical Lnhc Inc
Publication of IL313526A publication Critical patent/IL313526A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL313526A 2021-12-17 2022-12-16 Nitric oxide-releasing nasal preparations and methods of using them IL313526A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163290928P 2021-12-17 2021-12-17
PCT/US2022/081754 WO2023114971A1 (en) 2021-12-17 2022-12-16 Nitric oxide-releasing nasal compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
IL313526A true IL313526A (en) 2024-08-01

Family

ID=86773604

Family Applications (1)

Application Number Title Priority Date Filing Date
IL313526A IL313526A (en) 2021-12-17 2022-12-16 Nitric oxide-releasing nasal preparations and methods of using them

Country Status (9)

Country Link
US (1) US20250049841A1 (enExample)
EP (1) EP4447946A4 (enExample)
JP (1) JP2024547022A (enExample)
KR (1) KR20240125633A (enExample)
CN (1) CN118742298A (enExample)
AU (1) AU2022409833A1 (enExample)
CA (1) CA3240044A1 (enExample)
IL (1) IL313526A (enExample)
WO (1) WO2023114971A1 (enExample)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1871433B1 (en) * 2005-03-24 2009-04-22 NOLabs AB Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
EP1888510A4 (en) * 2005-05-27 2013-01-16 Univ North Carolina NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS
WO2010044875A2 (en) * 2008-10-16 2010-04-22 Novan, Inc. Nitric oxide releasing particles for oral care applications
AU2015229626B2 (en) * 2014-03-14 2021-05-20 Sanotize Research And Development Corp. Treating diseases using nitric oxide releasing solutions
WO2016160089A1 (en) * 2015-03-27 2016-10-06 Novan, Inc. Topical antiviral compositions, delivery systems, and methods of using the same
EP3177262A4 (en) * 2014-08-08 2018-04-18 Novan Inc. Topical emulsions
US11166980B2 (en) * 2016-04-13 2021-11-09 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
GB2599818B (en) * 2019-06-04 2024-01-31 Thirty Respiratory Ltd Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
CN112791096A (zh) * 2020-12-31 2021-05-14 南京诺令生物科技有限公司 一种可自提供一氧化氮的洗鼻盐及其应用

Also Published As

Publication number Publication date
EP4447946A4 (en) 2026-01-07
AU2022409833A1 (en) 2024-06-20
WO2023114971A1 (en) 2023-06-22
US20250049841A1 (en) 2025-02-13
CA3240044A1 (en) 2023-06-22
EP4447946A1 (en) 2024-10-23
CN118742298A (zh) 2024-10-01
JP2024547022A (ja) 2024-12-26
KR20240125633A (ko) 2024-08-19

Similar Documents

Publication Publication Date Title
JP6651499B2 (ja) 局所用抗ウイルス薬組成物及びこれを使用する方法
TR201807714T4 (tr) İnhalasyon tedavisine yönelik nebülize antibiyotikler.
US20230075885A1 (en) Compositions and applications thereof
US11826382B2 (en) Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
Lee et al. A novel inhaled multi-pronged attack against respiratory bacteria
US20220110968A1 (en) Compositions and methods to disinfect, treat and prevent microbial infections
TW202227104A (zh) 預防感染之組合物
US20250049841A1 (en) Nitric oxide-releasing nasal compositions and methods of use thereof
US11642372B2 (en) Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
JP2024128022A (ja) 微生物感染を消毒、処置および予防するための組成物および方法
CN113244262A (zh) 一种用于预防及治疗呼吸道感染性疾病的吸入粉雾制剂
US12042514B2 (en) Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
US20250352558A1 (en) Water-soluble cannabidiol compositions and method for preparation of water-soluble cannabidiol
WO2023021329A1 (en) Compositions and methods to disinfect, treat and prevent microbial infections
CN102369012B (zh) 氧化氘用于治疗病毒性呼吸道疾病的用途
AU2022410715B2 (en) Pharmaceutical combination for the treatment of the respiratory infection caused by sars-cov-2
US11986516B2 (en) Compositions and methods for treatment of SARS-COV-2
US20240091253A1 (en) THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES
US20240000878A1 (en) Methods for treatment and/or prevention of viral infections
CN113244263A (zh) 一种用于预防及治疗呼吸道感染性疾病的雾化吸入制剂
HK40007474A (en) Liquid inhalation formulation comprising rpl554
HK40007474B (en) Liquid inhalation formulation comprising rpl554